To offer cross-protection against diverse influenza virus variants, nanoparticle vaccines can produce pivotal cellular and mucosal immune responses that enhance vaccine efficacy and broaden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback